IFNG and myeloid sarcoma: Because EAE and MS are diseases mainly mediated by myelin-specific T cells, in this study we addressed the impact of IFN-γ treatment on peripheral and CNS infiltrating CD4+ T cell subpopulations, including Th1, Th17, and Treg cells, in EAE.